Presentation is loading. Please wait.

Presentation is loading. Please wait.

Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a.

Similar presentations


Presentation on theme: "Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a."— Presentation transcript:

1 Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)‏ by Teresa V. Halbsguth, Lucia Nogová, Horst Mueller, Michal Sieniawski, Dennis A. Eichenauer, Thomas Schober, Hiltrud Nisters-Backes, Peter Borchmann, Volker Diehl, Andreas Engert, and Andreas Josting Blood Volume 116(12):2026-2032 September 23, 2010 ©2010 by American Society of Hematology

2 Patients assessed and included for final analysis. Teresa V. Halbsguth et al. Blood 2010;116:2026-2032 ©2010 by American Society of Hematology

3 Kaplan-Meier plots of BACOPP. (A) Kaplan-Meier analysis of freedom from treatment failure (FFTF). Teresa V. Halbsguth et al. Blood 2010;116:2026-2032 ©2010 by American Society of Hematology


Download ppt "Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a."

Similar presentations


Ads by Google